Search research articles
Contact Us
Filters
Showing results (231-240 of 253) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816
Oliver W Press, Hongli Li, Heiko Schöder, et al.
Blood
|
September 8, 2016
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
Anthony R Mato, Chadi Nabhan, Paul M Barr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience
Muhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
American Journal of Hematology
|
June 6, 2015
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort
Andrew M Evens, Jennifer A Kanakry, Laurie H Sehn, et al.
Blood Advances
|
August 21, 2023
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma
Raphael E Steiner, Steven R Hwang, Arushi Khurana, et al.
British Journal of Haematology
|
December 22, 2018
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
Brian T Hill, Loretta Nastoupil, Allison M Winter, et al.
Blood Cancer Journal
|
August 7, 2024
Identification of genetic subtypes in follicular lymphoma
Victoria Shelton, Rajesh Detroja, Ting Liu, et al.
Blood Advances
|
September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
Sanjal H Desai, Michael A Spinner, Andrew M Evens, et al.
Blood Cancer Journal
|
June 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma
Sanjal H Desai, Susan M Geyer, Levi Pederson, et al.
Nature Genetics
|
November 13, 2012
The genetic landscape of mutations in Burkitt lymphoma
Cassandra Love, Zhen Sun, Dereje Jima, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 253) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816
Oliver W Press, Hongli Li, Heiko Schöder, et al.
Blood
|
September 8, 2016
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
Anthony R Mato, Chadi Nabhan, Paul M Barr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience
Muhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
American Journal of Hematology
|
June 6, 2015
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort
Andrew M Evens, Jennifer A Kanakry, Laurie H Sehn, et al.
Blood Advances
|
August 21, 2023
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma
Raphael E Steiner, Steven R Hwang, Arushi Khurana, et al.
British Journal of Haematology
|
December 22, 2018
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
Brian T Hill, Loretta Nastoupil, Allison M Winter, et al.
Blood Cancer Journal
|
August 7, 2024
Identification of genetic subtypes in follicular lymphoma
Victoria Shelton, Rajesh Detroja, Ting Liu, et al.
Blood Advances
|
September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
Sanjal H Desai, Michael A Spinner, Andrew M Evens, et al.
Blood Cancer Journal
|
June 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma
Sanjal H Desai, Susan M Geyer, Levi Pederson, et al.
Nature Genetics
|
November 13, 2012
The genetic landscape of mutations in Burkitt lymphoma
Cassandra Love, Zhen Sun, Dereje Jima, et al.
Page
of 26